However, there is no sufficient and effective evidence for the pathogenesis of HJURP in a variety of cancers, and it remains unclear about whether HJURP plays a role in TME, cell cycle progression, tumor treatment and prognosis through a common molecular mechanism in the context of immunocytological action. Here, HJURP is linked to cancer.